Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04366791 · ClinicalTrials.gov registry record · Phase 1
Radiation Eliminates Storming Cytokines and Unchecked Edema as a 1-Day Treatment for COVID-19
A Phase 1 study, sponsored by Emory University.
- Terminated
- Registry status
- Phase 1
- Development phase
- 47
- Enrollment target
NCT04366791 is a Phase 1 study that was terminated before completion, run by Emory University. The registered enrollment target is 47 participants.
The verdict
NCT04366791, a Phase 1 study, was terminated before completion, sponsored by Emory University.
- TERMINATED
- Registry status
- Phase 1
- Development phase
- 47 participants
- Enrollment target
Study Summary
This phase I/II trial studies low-dose radiation therapy as a focal anti-inflammatory treatment for patients with pneumonia or SARS associated with COVID-19 infection.
Interventions
- RADIATION Low Dose Radiation Therapy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 47 participants |
| Start Date | 2020-04-24 |
| Est. Completion | 2022-03-11 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04366791
The ClinicalTrials.gov registry entry for NCT04366791 describes a study currently listed as terminated, categorized as Phase 1. The registered enrollment target is 47 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Emory University, which has 1,208 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Low Dose Radiation Therapy is the first listed.
NCT04366791 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04366791 about?
NCT04366791 is a clinical study titled "Radiation Eliminates Storming Cytokines and Unchecked Edema as a 1-Day Treatment for COVID-19". This phase I/II trial studies low-dose radiation therapy as a focal anti-inflammatory treatment for patients with pneumonia or SARS associated with COVID-19 infection.
What is the current status of trial NCT04366791?
This trial is currently terminated. It is a Phase 1 study. The enrollment target is 47 participants. The study started on 2020-04-24. Estimated completion is 2022-03-11.
What interventions are being tested in trial NCT04366791?
The interventions under investigation include: Low Dose Radiation Therapy (RADIATION).
Who is sponsoring clinical trial NCT04366791?
This trial is sponsored by Emory University, which has 1,208 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.